Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Michl

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
International Journal of Molecular Sciences|June 18, 2020
RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal AdenocarcinomaMarkus Glaß, Patrick Michl, And Stefan Hüttelmaier
Inflammatory Bowel Diseases|June 13, 2020
Inflammatory Bowel Disease and COVID-19-"Preventive" Sick Certificates as a Frequent Coping Strategy in the Face of the PandemicFranziska Schlabitz, Niels Teich, Patrick Michl, et al.
Cancers|November 12, 2013
Screening technologies for target identification in pancreatic cancerPatrick Michl, Stefanie Ripka, Thomas Gress, et al.
Digestion|July 21, 2017
The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine TumorsSebastian Krug, Thomas M Gress, Patrick Michl, et al.
European Journal of Gastroenterology & Hepatology|December 8, 2017
Family planning in inflammatory bowel disease: childlessness and disease-related concerns among female patientsJens Walldorf, Susanne Brunne, Fleur S Gittinger, et al.
World Journal of Hepatology|December 17, 2010
Liver-specific therapies for metastases of neuroendocrine pancreatic tumorsVolker Fendrich, Patrick Michl, Nils Habbe, et al.
Cancers|May 14, 2022
IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2Florian Sperling, Danny Misiak, Stefan Hüttelmaier, et al.
International Journal of Molecular Sciences|January 23, 2024
Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive ProteinMarie Stute, Martin Kreysing, Markus Zorn, et al.
European Journal of Gastroenterology & Hepatology|August 28, 2018
High frequency of secondary, but not primary ocular manifestations of inflammatory bowel disease in patients treated at a tertiary care centerJens Walldorf, Maria Twarz, Celestina Schober, et al.
Journal of Medical Ultrasound|February 27, 2023
Presence of Color Transition in Biopsy Specimens Predicts Outcome of Liver Lesion BiopsiesFleur Sophie Gittinger, Laura Wetterich, Patrick Michl, et al.
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
International Journal of Molecular Sciences|June 18, 2020
RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal AdenocarcinomaMarkus Glaß, Patrick Michl, And Stefan Hüttelmaier
Inflammatory Bowel Diseases|June 13, 2020
Inflammatory Bowel Disease and COVID-19-"Preventive" Sick Certificates as a Frequent Coping Strategy in the Face of the PandemicFranziska Schlabitz, Niels Teich, Patrick Michl, et al.
Cancers|November 12, 2013
Screening technologies for target identification in pancreatic cancerPatrick Michl, Stefanie Ripka, Thomas Gress, et al.
Digestion|July 21, 2017
The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine TumorsSebastian Krug, Thomas M Gress, Patrick Michl, et al.
European Journal of Gastroenterology & Hepatology|December 8, 2017
Family planning in inflammatory bowel disease: childlessness and disease-related concerns among female patientsJens Walldorf, Susanne Brunne, Fleur S Gittinger, et al.
World Journal of Hepatology|December 17, 2010
Liver-specific therapies for metastases of neuroendocrine pancreatic tumorsVolker Fendrich, Patrick Michl, Nils Habbe, et al.
Cancers|May 14, 2022
IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2Florian Sperling, Danny Misiak, Stefan Hüttelmaier, et al.
International Journal of Molecular Sciences|January 23, 2024
Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive ProteinMarie Stute, Martin Kreysing, Markus Zorn, et al.
European Journal of Gastroenterology & Hepatology|August 28, 2018
High frequency of secondary, but not primary ocular manifestations of inflammatory bowel disease in patients treated at a tertiary care centerJens Walldorf, Maria Twarz, Celestina Schober, et al.
Journal of Medical Ultrasound|February 27, 2023
Presence of Color Transition in Biopsy Specimens Predicts Outcome of Liver Lesion BiopsiesFleur Sophie Gittinger, Laura Wetterich, Patrick Michl, et al.
Pageof 16